Back
10 November 2026
As previously reported, the athlete tested positive for Meldonium after providing a sample on 14 December 2024 during an in-competition doping control conducted at the 2024 GAMMA World Championships in Tangerang, Indonesia.
When notified of the case, the athlete was provisionally suspended with immediate effect. However, the athlete did not respect the conditions of the provisional suspension and was therefore not given any credit for the provisional suspension served.
Meldonium is prohibited under the 2024-2026 WADA Prohibited Lists as S.4.4.3 Metabolic Modulator. It is prohibited at all times (in- and out-of-competition) and classified as a non-specified substance. Meldonium may enhance sports performance by improving endurance and shortening recovery times.
The athlete further admitted having used an infusion of more than a total of 100 mL per 12-hour period, which considered a Prohibited Method under M.2.2 of the 2024-2026 WADA Prohibited Lists.
The athlete agreed with the consequences for her ADRVs under the GAMMA anti-doping rules as proposed by the ITA. Accordingly, the case was resolved via an agreement on consequences.¹
Due to her early admission of the ADRVs, the athlete was entitled to a one-year reduction of the applicable period of ineligibility as set forth in article 10.8.1 of the GAMMA anti-doping rules.²
The three-year period of ineligibility is from 20 October 2026 until 19 October 2029. Additionally, the athlete’s individual results at the 2024 GAMMA World Championships are disqualified, including forfeiture of medals, points and prizes. All individual competitive results obtained by the athlete from the date of sample collection (14 December 2024) onwards are also disqualified.
The decision may be challenged before the appeals division of the Court of Arbitration for Sport (CAS) by the parties with a right of appeal in accordance with Article 13.2.3 of the GAMMA anti-doping rules.
The ITA will not comment further on this case.
¹ Athletes have the right to choose not to have their case referred to a hearing panel. In these instances, the anti-doping organisation will assess the athlete’s case file and establish the applicable consequences pursuant to the anti-doping rules and the athlete will have the right to accept the proposed consequences. If the athlete refuses the proposed consequences, the case is transferred to a hearing panel. This resolution mechanism is provided for in articles 8.3.1 of the GAMMA anti-doping rules and 8.3 of the World Anti-Doping Code and is commonly referred to as an agreement on consequences, which is deemed a GAMMA/ITA decision.
² Article 10.8.1 of the GAMMA anti-doping rules (and World Anti-Doping Code) provides for a one-year reduction for certain ADRVs based on early admission and acceptance of sanction. This applies where an athlete after being notified by GAMMA/ITA of a potential ADRV that carries an asserted period of Ineligibility of four (4) or more years, admits the violation and accepts the asserted period of Ineligibility no later than twenty (20) days after receiving notice of an ADRV charge. Where the athlete receives the one-year reduction under Article 10.8.1, of the GAMMA anti-doping rules no further reduction in the period of Ineligibility is allowed.
